Nimotuzumab with chemoradiotherapy for newly diagnosed, high-risk, locally advanced squamous cervical cancer (CC11): A prospective single-arm phase II study.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Shuangzheng Jia, Jusheng An, Xi Yang, Wei Li, Yuanyuan Zhang, Manni Huang
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410814124